Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase NA 1Phase 4 1

Status

Completed 2Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Delirium 4Recurrence 2Neoplasm Metastasis 2Nausea 2Vomiting 1Neoplasms 1Haloperidol 1Glioblastoma 1Breast Neoplasms 1

Interventions

Dexmedetomidine 5Saline Solution 4Haloperidol 4Sodium Chloride 3Propofol 2Lorazepam 2suvorexant 1remimazolam 1haloperidol decanoate 1flurbiprofen axetil 1dexamethasone 21-phosphate 1Vitamin E 1Surveys and Questionnaires 1Standard of Care 1Sevoflurane 1Practice Guidelines as Topic 1Olanzapine 1Midazolam 1Melatonin 1Interviews as Topic 1Injections 1Inhalation 1Ibuprofen 1Donepezil 1Dexamethasone 1Chlorpromazine 1Anesthesia, Spinal 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Delirium × Haloperidol × Clear all
NCT03021486 2026-03-18

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
70 enrolled 20 charts

Delirium, Neoplasm Metastasis, Recurrence

NCT03743649 2025-12-26

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
110 enrolled

Delirium, Neoplasm Metastasis, Recurrence

NCT03489551 2018-05-22

PHDC

University of Iowa

Phase 4 Completed
17 enrolled 5 charts

Delirium

NCT01539733 2017-04-07

Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer

Amsterdam UMC, location VUmc

Phase NA Completed
101 enrolled

Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡